(IN BRIEF) Bayer has invested $250 million in a new cell therapy production plant in Berkeley, California, USA. This investment aims to support the production of materials for clinical trials and potential commercial launches of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), an … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science
Tagged Bayer, Bemdaneprocel, Berkeley, BRT-DA01, California, Cell Therapy Plant, Holger Weintritt, Parkinson's disease, partnership, Seth Ettenberg, Stefan Oelrich, sustainability, USA
(IN BRIEF) Researchers from the Brain Repair laboratory at the University of Helsinki have investigated whether a protein called cerebral dopamine neurotrophic factor (CDNF) has potential as a treatment for intracerebral haemorrhage, a condition where bleeding into brain tissue causes … Read the full press release
Posted in Education, Finland, Healthcare, Management, News, Pharma & Biotech, Science
Tagged brain hemorrhage, cerebral dopamine neurotrophic factor (CDNF), Dr. Vassileios Stratoulias, intracerebral haemorrhage, Mikko Airavaara, Parkinson's disease, protein, protein therapy, researchers, treatment, University of Helsinki
(PRESS RELEASE) ENSCHEDE, Netherlands, 28-Feb-2022 — /EuropaWire/ — University of Twente, a Enschede, NL based public technical university, has announced that its associate professor Kerensa Broersen has been granted Vici funding from NWO, the Dutch Research Council. Kerensa Broersen, associate … Read the full press release
Posted in Education, Financial, Healthcare, Netherlands, Science, Technology
Tagged autism spectrum disorders, Brain, brain function, brain tumours, brain-related disorders, intestinal bacteria, Kerensa Broersen, multiple sclerosis, neurodegeneration, NWO, Parkinson's disease, schizophrenia, Stem cells, TTW, Veni, Vici funding, Vici grant, Vidi grants, ZonMw
New treatment might have the potential to slow or stop the progression of Parkinson’s disease. VALBY, 12-Sep-2018 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) begins clinical development of yet another potential new treatment of Parkinson’s disease with the enrollment of the … Read the full press release
Posted in Denmark, Healthcare, Pharma & Biotech
Tagged antibody, brain_cells, Genmab, Lundbeck, Parkinson's, Parkinson's disease, proteins
Lu AF28996 is the third compound added to Lundbeck’s clinical development pipeline in 2018. VALBY, 28-Jun-2018 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) again expands its pipeline of clinical development projects with the initiation of a phase I study of a … Read the full press release
Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson’s disease. CAMBRIDGE, 20-Feb-2018 — /EuropaWire/ — The international team, led by the University of Cambridge, found … Read the full press release
AMSTERDAM, 22-Jun-2017 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an agreement to acquire Electrical Geodesics, Inc. (EGI), a US-based medical device company that designs, develops and commercializes a range of non-invasive … Read the full press release
Posted in Healthcare, Netherlands, Technology
Tagged Don Tucker, Electrical Geodesics, Joe Burnett, medical device company, Parkinson's disease, Royal Philips
DUBLIN, 18-11-2014 — /EuropaWire/ — Scientists at Trinity College Dublin have made an important breakthrough in our understanding of Parkin – a protein that regulates the repair and replacement of nerve cells within the brain. This breakthrough generates a new … Read the full press release
Newcastle, UK, 27-10-2014 — /EuropaWire/ — Researchers at Newcastle University have found a definitive link between gait – the way someone walks – and early changes in cognitive function in people with Parkinson’s disease. And the findings, published today (22nd October … Read the full press release
Posted in Education, Healthcare, United Kingdom
Tagged dementia, gait, Lynn Rochester, Newcastle University, Parkinson's disease
19-8-2013 — /EuropaWire/ — Company Highlights April – June 2013 Biotie obtained an exclusive option to acquire Neurelis, Inc., a private specialty pharmaceutical company based in San Diego, CA, focused on developing products for epilepsy and other disorders of the central nervous … Read the full press release
Posted in Business, Financial, Finland, Healthcare, Investment, Pharma & Biotech
Tagged Alzheimer's disease, Biotie, Biotie Therapies Corp, BTT-1023, cognitive disorders, drugs for neurodegenerative and psychiatric disorders, fibrotic liver disease, Lundbeck A/S, nalmefene, nepicastat, Neurelis, Parkinson's disease, post-traumatic stress disorder, SELINCRO, SYN120, The National Institute on Drug Abuse, Timo Veromaa, Tozadenant, VAP-1 antibody, Virve Nurmi
15-8-2013 — /EuropaWire/ — Researchers have discovered how genetic mutations linked to Parkinson’s disease might play a key role in the death of brain cells, potentially paving the way for the development of more effective drug treatments. In the new study, … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged damaged cells, David Weston, Dr Heike Laman, Dr Helene Plun-Favreau, Fbxo7, genetic mutations, Mitochondria, mitophagy, Parkinson's disease, PINK1-Parkin pathway, Professor Hugh Perry, Professor Nicholas Wood, University College London, University of Cambridge, University of Sheffield
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
